1. Home
  2. BEKE vs NTRA Comparison

BEKE vs NTRA Comparison

Compare BEKE & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BEKE

KE Holdings Inc (each representing three)

HOLD

Current Price

$17.23

Market Cap

18.8B

Sector

Finance

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEKE
NTRA
Founded
2001
2003
Country
China
United States
Employees
N/A
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8B
27.0B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
BEKE
NTRA
Price
$17.23
$244.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
16
Target Price
$24.36
$227.69
AVG Volume (30 Days)
5.1M
1.7M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
2.10%
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$14,540,474,652.00
$2,116,676,000.00
Revenue This Year
$7.14
$32.77
Revenue Next Year
$4.90
$16.51
P/E Ratio
$41.17
N/A
Revenue Growth
25.42
38.17
52 Week Low
$15.39
$125.38
52 Week High
$25.17
$245.59

Technical Indicators

Market Signals
Indicator
BEKE
NTRA
Relative Strength Index (RSI) 51.79 80.03
Support Level $16.47 $233.67
Resistance Level $17.55 $240.18
Average True Range (ATR) 0.38 7.39
MACD 0.06 0.68
Stochastic Oscillator 62.78 97.49

Price Performance

Historical Comparison
BEKE
NTRA

About BEKE KE Holdings Inc (each representing three)

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: